Lacrimal duct diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged at least 20 years old men and women; 2. duration: unlimited; 3. Indications: patients diagnosed as functional epiphora, lacrimal duct stenosis, lacrimal duct obstruction, chronic dacryocystitis, acute dacryocystitis; 4. Subjects have treatment needs, fully understand the condition, and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who did not meet the criteria for selection; (2) those who used glucocorticoid therapy within three months; (3) those who used oral or intravenous antibiotics within three months; (4) those who used antibiotic ophthalmic treatment within one week (except acute dacryocystitis); (5) those who suffered from blepharitis, blepharitis, entropion, ectropion, keratitis and other external eye and ocular diseases within three months or who had received eye surgery; (6) patients with severe skin diseases such as acne and rosacea; (7) patients with severe systemic diseases such as diabetes mellitus, autoimmune diseases, renal insufficiency and dialysis therapy; (8) medical history, personal history and allergic history that may interfere with the test results or increase the risk of patients according to the judgement of the researchers; (9) patients who have participated in other drug clinical trials in the last three months; (10) can not regularly follow-up or failure to cooperate with researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and type of flora; | — |
Countries
China
Contacts
Tianjin Medical University